Results 151 to 160 of about 7,470 (208)

Advances in Non-CPAP Management of Obstructive Sleep Apnea: Spotlight on Pharmacological Therapies. [PDF]

open access: yesJ Pers Med
Siciliano M   +5 more
europepmc   +1 more source

Association Between Prescribing of Antimuscarinic Drugs and Antimuscarinic Adverse Effects in Older People

Expert Review of Clinical Pharmacology, 2010
Many commonly prescribed medications have antimuscarinic side effects. These can be severe and disabling, but it is not always possible to predict which patients will suffer these effects. The development of practical tools that predict the likelihood of adverse drug reactions would aid rational prescribing, thereby improving patient safety and ...
Arduino Aleksander Mangoni, Roy L. Soiza
exaly   +4 more sources

Antimuscarinic Drugs for Overactive Bladder and Their Potential Effects on Cognitive Function in Older Patients

open access: yesJournal of the American Geriatrics Society, 2005
Antimuscarinic agents are the predominant pharmacological treatment for patients with overactive bladder (OAB). These drugs are thought to act primarily through antagonism at muscarinic M-3 receptors located at neuromuscular junctions in the human ...
Jack W Tsao   +2 more
exaly   +2 more sources

Anticholinergic, Antimuscarinic Bronchodilators

American Review of Respiratory Disease, 1984
Abstract The anticholinergic, antimuscarinic compounds are potent and hitherto neglected bronchodilators. Although atropine itself has drawbacks, principally related to its rapid absorption and consequent systemic side effects, its quaternary ammonium congeners, atropine methonitrate and ipratropium bromide, are poorly absorbed.
N J, Gross, M S, Skorodin
openaire   +2 more sources

Local Effects of Antimuscarinics

Urologic Clinics of North America, 2006
Overactive bladder (OAB) syndrome has been estimated to occur in nearly 17% of the population. The most common drug treatments for OAB are antimuscarinic agents that act to increase bladder capacity and decrease the urge to urinate during the storage phase.
Hitoshi, Masuda   +5 more
openaire   +2 more sources

Cyclovinylogues of some Antimuscarinic Drugs

Archiv der Pharmazie, 1985
AbstractSyntheses of some cyclovinylogues of antimuscarinic drugs, in which a benzene ring is interposed between the methylene groups of the basic chain, are reported. The pharmacological properties of the products were investigated.
Valenti P   +4 more
openaire   +3 more sources

Anticholinergics/Antimuscarinic Drugs in Asthma

Current Allergy and Asthma Reports, 2014
Anticholinergic alkaloids have been used for thousands of years for the relief of bronchoconstriction and other respiratory symptoms, and their use in the treatment of chronic obstructive pulmonary disease is well established. Acetylcholine, acting through muscarinic receptor (M) receptor, modulates multiple physiologic functions pertinent to asthma ...
Xavier, Soler, Joe, Ramsdell
openaire   +2 more sources

The Q-T interval and antimuscarinic drugs

Current Bladder Dysfunction Reports, 2005
Antimuscarinic drugs form the mainstay of pharmacotherapy for the treatment of overactive bladder. The primary sites of activity of the agents for the desired therapeutic effect are the M3 and M2 receptors of the bladder. Drug interaction with other non-vesical muscarinic receptors produces a range of undesired adverse events.
Roger, Dmochowski, David R, Staskin
openaire   +2 more sources

Antimuscarinic management of overactive bladder

British Journal of Community Nursing, 2005
The symptoms of an overactive bladder (OAB) has a negative effect on the health-related quality of life of a sufferer. Many do not seek help and up to 73% of those of who are assessed do not take medication to relieve their symptoms. The key to managing this condition is a multidisciplinary approach to conservative behaviour therapy in the form of ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy